Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes

Identifieur interne : 000257 ( Hal/Checkpoint ); précédent : 000256; suivant : 000258

Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes

Auteurs : Michel Monsigny [France] ; Annie-Claude Roche [France] ; Patrick Midoux [France] ; Roger Mayer [France]

Source :

RBID : Hal:hal-02163748

Abstract

Cell surface receptors are good candidates to selectively target drugs, oligonucleotides or even genes by making use of their specific ligands. A large number of mammalian cells express cell surface sugar-binding proteins, also called “membrane lectins”. Therefore, sugars may be used as specific recognition signals to specifically deliver biological active components. Tens of membrane lectins with different sugar specificities have been characterized; some of them actively carry their ligands to intracellular compartments, including endsomes, lysosomes and, in some cases, Golgi apparatus.In this review, we summarize the main properties of neoglycoproteins and glycosylated polymers; they have been developed to study the properties of endogenous lectins and to carry various drugs. Glycoconjugates have been successfully used to carry biological response modifiers such as N-acetylmuramyldipeptide. N-Acetylmuramyldipeptide is, in vitro, hundreds of times more efficient in rendering macrophages tumoricidal when it is bound to this type of carrier. In vivo, the N-acetylmuramyldipeptide bound to glycoconjugates containing mannose in a terminal non-reducing position, induces the eradication of lung metastases, occurring when treatment is started, in 70% of mice; free N-acetylmuramyldipeptide is strictly inactive. Similarly, N-acetylmuramyldipeptide bound to the same glycoconjugates induces an active antiviral effect.Glycoconjugates are also suitable for carrying antisense oligonucleotides specific for viral sequences. Antisense oligonucleotides protected at both ends and linked through a disulfide bridge to the glycoconjugates are 10 times more efficient than the corresponding free oligonucleotides.Poly-l-lysine containing about 190 lysine residues has been substituted by three components: sugars as recognition signal, antiviral (or antiparasite) agents as therapeutic elements and gluconoic acid as neutralizing and solubilizing agent. This type of neutral, highly water-soluble glycosylated polymer is a very efficient carrier to deliver drugs in infected cells according to the nature of the sugar borne on the polymer and to the specificity of the lectin present at the surface of the infected cells.Finally, poly-l-lysine (190 residues) partially substituted with sugars (60 units) is a polycationic glycosylated polymer which easily makes complexes with plasmids. These complexes are very efficient in transfecting cells in a sugar-dependent manner. The expression of reporter gene is greatly enhanced when cells are incubated with the plasmid-glycosylated poly-l-lysine complex in the presence of either 100 μM chloroquine or 10 μM fusogenic docosapeptide. Furthermore, this transfection method leads to a much larger number of stable transfectants than the classical method using calcium phosphate precipitate. The general properties of glycosylated proteins and of glycosylated polymers are presented and their efficiency in targeting genes in comparison with that of other available targeted transfection methods is discussed.


Url:
DOI: 10.1016/0169-409X(94)90003-5

Links toward previous steps (curation, corpus...)


Links to Exploration step

Hal:hal-02163748

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes</title>
<author>
<name sortKey="Monsigny, Michel" sort="Monsigny, Michel" uniqKey="Monsigny M" first="Michel" last="Monsigny">Michel Monsigny</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Roche, Annie Claude" sort="Roche, Annie Claude" uniqKey="Roche A" first="Annie-Claude" last="Roche">Annie-Claude Roche</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Midoux, Patrick" sort="Midoux, Patrick" uniqKey="Midoux P" first="Patrick" last="Midoux">Patrick Midoux</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Roger" sort="Mayer, Roger" uniqKey="Mayer R" first="Roger" last="Mayer">Roger Mayer</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-02163748</idno>
<idno type="halId">hal-02163748</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-02163748</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-02163748</idno>
<idno type="doi">10.1016/0169-409X(94)90003-5</idno>
<date when="1994-04">1994-04</date>
<idno type="wicri:Area/Hal/Corpus">000101</idno>
<idno type="wicri:Area/Hal/Curation">000101</idno>
<idno type="wicri:Area/Hal/Checkpoint">000257</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000257</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes</title>
<author>
<name sortKey="Monsigny, Michel" sort="Monsigny, Michel" uniqKey="Monsigny M" first="Michel" last="Monsigny">Michel Monsigny</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Roche, Annie Claude" sort="Roche, Annie Claude" uniqKey="Roche A" first="Annie-Claude" last="Roche">Annie-Claude Roche</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Midoux, Patrick" sort="Midoux, Patrick" uniqKey="Midoux P" first="Patrick" last="Midoux">Patrick Midoux</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
<author>
<name sortKey="Mayer, Roger" sort="Mayer, Roger" uniqKey="Mayer R" first="Roger" last="Mayer">Roger Mayer</name>
<affiliation wicri:level="1">
<hal:affiliation type="laboratory" xml:id="struct-451" status="VALID">
<idno type="IdRef">170121070</idno>
<idno type="RNSR">196717612S</idno>
<orgName>Centre de biophysique moléculaire</orgName>
<orgName type="acronym">CBM</orgName>
<date type="start">1967-01-01</date>
<desc>
<address>
<addrLine>Rue Charles Sadron 45071 ORLEANS CEDEX 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://cbm.cnrs-orleans.fr/</ref>
</desc>
<listRelation>
<relation name="UPR4301" active="#struct-300297" type="direct"></relation>
<relation name="UPR4301" active="#struct-303623" type="direct"></relation>
<relation name="UPR4301" active="#struct-441569" type="direct"></relation>
</listRelation>
<tutelles>
<tutelle name="UPR4301" active="#struct-300297" type="direct">
<org type="institution" xml:id="struct-300297" status="VALID">
<idno type="IdRef">026402971</idno>
<idno type="ISNI">0000000121581666 </idno>
<orgName>Université d'Orléans</orgName>
<orgName type="acronym">UO</orgName>
<desc>
<address>
<addrLine>Château de la Source - Avenue du Parc Floral - BP 6749 - 45067 Orléans cedex 2</addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.univ-orleans.fr/</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-303623" type="direct">
<org type="institution" xml:id="struct-303623" status="VALID">
<idno type="IdRef">026388278</idno>
<orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
<orgName type="acronym">INSERM</orgName>
<desc>
<address>
<addrLine>101, rue de Tolbiac, 75013 Paris </addrLine>
<country key="FR"></country>
</address>
<ref type="url">http://www.inserm.fr</ref>
</desc>
</org>
</tutelle>
<tutelle name="UPR4301" active="#struct-441569" type="direct">
<org type="institution" xml:id="struct-441569" status="VALID">
<idno type="IdRef">02636817X</idno>
<idno type="ISNI">0000000122597504</idno>
<orgName>Centre National de la Recherche Scientifique</orgName>
<orgName type="acronym">CNRS</orgName>
<date type="start">1939-10-19</date>
<desc>
<address>
<country key="FR"></country>
</address>
<ref type="url">http://www.cnrs.fr/</ref>
</desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName>
<settlement type="city">Orléans</settlement>
<region type="old region" nuts="2">Région Centre</region>
<region type="region" nuts="2">Centre-Val de Loire</region>
</placeName>
<orgName type="university">Université d'Orléans</orgName>
<orgName type="institution" wicri:auto="newGroup">Centre Val de Loire Université</orgName>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.1016/0169-409X(94)90003-5</idno>
<series>
<title level="j">Advanced Drug Delivery Reviews</title>
<idno type="ISSN">0169-409X</idno>
<imprint>
<date type="datePub">1994-04</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Cell surface receptors are good candidates to selectively target drugs, oligonucleotides or even genes by making use of their specific ligands. A large number of mammalian cells express cell surface sugar-binding proteins, also called “membrane lectins”. Therefore, sugars may be used as specific recognition signals to specifically deliver biological active components. Tens of membrane lectins with different sugar specificities have been characterized; some of them actively carry their ligands to intracellular compartments, including endsomes, lysosomes and, in some cases, Golgi apparatus.In this review, we summarize the main properties of neoglycoproteins and glycosylated polymers; they have been developed to study the properties of endogenous lectins and to carry various drugs. Glycoconjugates have been successfully used to carry biological response modifiers such as N-acetylmuramyldipeptide. N-Acetylmuramyldipeptide is, in vitro, hundreds of times more efficient in rendering macrophages tumoricidal when it is bound to this type of carrier. In vivo, the N-acetylmuramyldipeptide bound to glycoconjugates containing mannose in a terminal non-reducing position, induces the eradication of lung metastases, occurring when treatment is started, in 70% of mice; free N-acetylmuramyldipeptide is strictly inactive. Similarly, N-acetylmuramyldipeptide bound to the same glycoconjugates induces an active antiviral effect.Glycoconjugates are also suitable for carrying antisense oligonucleotides specific for viral sequences. Antisense oligonucleotides protected at both ends and linked through a disulfide bridge to the glycoconjugates are 10 times more efficient than the corresponding free oligonucleotides.Poly-l-lysine containing about 190 lysine residues has been substituted by three components: sugars as recognition signal, antiviral (or antiparasite) agents as therapeutic elements and gluconoic acid as neutralizing and solubilizing agent. This type of neutral, highly water-soluble glycosylated polymer is a very efficient carrier to deliver drugs in infected cells according to the nature of the sugar borne on the polymer and to the specificity of the lectin present at the surface of the infected cells.Finally, poly-l-lysine (190 residues) partially substituted with sugars (60 units) is a polycationic glycosylated polymer which easily makes complexes with plasmids. These complexes are very efficient in transfecting cells in a sugar-dependent manner. The expression of reporter gene is greatly enhanced when cells are incubated with the plasmid-glycosylated poly-l-lysine complex in the presence of either 100 μM chloroquine or 10 μM fusogenic docosapeptide. Furthermore, this transfection method leads to a much larger number of stable transfectants than the classical method using calcium phosphate precipitate. The general properties of glycosylated proteins and of glycosylated polymers are presented and their efficiency in targeting genes in comparison with that of other available targeted transfection methods is discussed.</p>
</div>
</front>
</TEI>
<hal api="V3">
<titleStmt>
<title xml:lang="en">Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes</title>
<author role="aut">
<persName>
<forename type="first">Michel</forename>
<surname>Monsigny</surname>
</persName>
<idno type="halauthorid">200710</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Annie-Claude</forename>
<surname>Roche</surname>
</persName>
<idno type="halauthorid">191072</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Patrick</forename>
<surname>Midoux</surname>
</persName>
<email type="md5">c8f24a3cf955469aa969463cc1db0798</email>
<email type="domain">cnrs-orleans.fr</email>
<idno type="idhal" notation="string">patrick-midoux</idno>
<idno type="idhal" notation="numeric">176062</idno>
<idno type="halauthorid">67616</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Roger</forename>
<surname>Mayer</surname>
</persName>
<idno type="halauthorid">11470491</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<editor role="depositor">
<persName>
<forename>Laëtitia</forename>
<surname>LEGOUPIL</surname>
</persName>
<email type="md5">e9a3fa0bdfd22a9d0a2d2ac46e7772a2</email>
<email type="domain">cnrs-orleans.fr</email>
</editor>
</titleStmt>
<editionStmt>
<edition n="v1" type="current">
<date type="whenSubmitted">2019-06-24 15:26:06</date>
<date type="whenModified">2019-06-25 01:34:38</date>
<date type="whenReleased">2019-06-24 15:26:06</date>
<date type="whenProduced">1994-04</date>
<ref type="externalLink" target="https://api.istex.fr/ark:/67375/6H6-7KXFXRNG-L/fulltext.pdf?sid=hal"></ref>
</edition>
<respStmt>
<resp>contributor</resp>
<name key="712555">
<persName>
<forename>Laëtitia</forename>
<surname>LEGOUPIL</surname>
</persName>
<email type="md5">e9a3fa0bdfd22a9d0a2d2ac46e7772a2</email>
<email type="domain">cnrs-orleans.fr</email>
</name>
</respStmt>
</editionStmt>
<publicationStmt>
<distributor>CCSD</distributor>
<idno type="halId">hal-02163748</idno>
<idno type="halUri">https://hal.archives-ouvertes.fr/hal-02163748</idno>
<idno type="halBibtex">monsigny:hal-02163748</idno>
<idno type="halRefHtml">Advanced Drug Delivery Reviews, Elsevier, 1994, 14 (1), pp.1-24. ⟨10.1016/0169-409X(94)90003-5⟩</idno>
<idno type="halRef">Advanced Drug Delivery Reviews, Elsevier, 1994, 14 (1), pp.1-24. ⟨10.1016/0169-409X(94)90003-5⟩</idno>
</publicationStmt>
<seriesStmt>
<idno type="stamp" n="CBM">Centre de biophysique moléculaire</idno>
<idno type="stamp" n="CNRS">CNRS - Centre national de la recherche scientifique</idno>
<idno type="stamp" n="INC-CNRS">Institut de Chimie du CNRS</idno>
<idno type="stamp" n="UNIV-ORLEANS">Université d'Orléans</idno>
</seriesStmt>
<notesStmt>
<note type="audience" n="2">International</note>
<note type="popular" n="0">No</note>
<note type="peer" n="1">Yes</note>
</notesStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes</title>
<author role="aut">
<persName>
<forename type="first">Michel</forename>
<surname>Monsigny</surname>
</persName>
<idno type="halauthorid">200710</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Annie-Claude</forename>
<surname>Roche</surname>
</persName>
<idno type="halauthorid">191072</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Patrick</forename>
<surname>Midoux</surname>
</persName>
<email type="md5">c8f24a3cf955469aa969463cc1db0798</email>
<email type="domain">cnrs-orleans.fr</email>
<idno type="idhal" notation="string">patrick-midoux</idno>
<idno type="idhal" notation="numeric">176062</idno>
<idno type="halauthorid">67616</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
<author role="aut">
<persName>
<forename type="first">Roger</forename>
<surname>Mayer</surname>
</persName>
<idno type="halauthorid">11470491</idno>
<affiliation ref="#struct-451"></affiliation>
</author>
</analytic>
<monogr>
<idno type="halJournalId" status="VALID">9656</idno>
<idno type="issn">0169-409X</idno>
<title level="j">Advanced Drug Delivery Reviews</title>
<imprint>
<publisher>Elsevier</publisher>
<biblScope unit="volume">14</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="pp">1-24</biblScope>
<date type="datePub">1994-04</date>
</imprint>
</monogr>
<idno type="doi">10.1016/0169-409X(94)90003-5</idno>
</biblStruct>
</sourceDesc>
<profileDesc>
<langUsage>
<language ident="en">English</language>
</langUsage>
<textClass>
<classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
<classCode scheme="halTypology" n="ART">Journal articles</classCode>
</textClass>
<abstract xml:lang="en">
<p>Cell surface receptors are good candidates to selectively target drugs, oligonucleotides or even genes by making use of their specific ligands. A large number of mammalian cells express cell surface sugar-binding proteins, also called “membrane lectins”. Therefore, sugars may be used as specific recognition signals to specifically deliver biological active components. Tens of membrane lectins with different sugar specificities have been characterized; some of them actively carry their ligands to intracellular compartments, including endsomes, lysosomes and, in some cases, Golgi apparatus.In this review, we summarize the main properties of neoglycoproteins and glycosylated polymers; they have been developed to study the properties of endogenous lectins and to carry various drugs. Glycoconjugates have been successfully used to carry biological response modifiers such as N-acetylmuramyldipeptide. N-Acetylmuramyldipeptide is, in vitro, hundreds of times more efficient in rendering macrophages tumoricidal when it is bound to this type of carrier. In vivo, the N-acetylmuramyldipeptide bound to glycoconjugates containing mannose in a terminal non-reducing position, induces the eradication of lung metastases, occurring when treatment is started, in 70% of mice; free N-acetylmuramyldipeptide is strictly inactive. Similarly, N-acetylmuramyldipeptide bound to the same glycoconjugates induces an active antiviral effect.Glycoconjugates are also suitable for carrying antisense oligonucleotides specific for viral sequences. Antisense oligonucleotides protected at both ends and linked through a disulfide bridge to the glycoconjugates are 10 times more efficient than the corresponding free oligonucleotides.Poly-l-lysine containing about 190 lysine residues has been substituted by three components: sugars as recognition signal, antiviral (or antiparasite) agents as therapeutic elements and gluconoic acid as neutralizing and solubilizing agent. This type of neutral, highly water-soluble glycosylated polymer is a very efficient carrier to deliver drugs in infected cells according to the nature of the sugar borne on the polymer and to the specificity of the lectin present at the surface of the infected cells.Finally, poly-l-lysine (190 residues) partially substituted with sugars (60 units) is a polycationic glycosylated polymer which easily makes complexes with plasmids. These complexes are very efficient in transfecting cells in a sugar-dependent manner. The expression of reporter gene is greatly enhanced when cells are incubated with the plasmid-glycosylated poly-l-lysine complex in the presence of either 100 μM chloroquine or 10 μM fusogenic docosapeptide. Furthermore, this transfection method leads to a much larger number of stable transfectants than the classical method using calcium phosphate precipitate. The general properties of glycosylated proteins and of glycosylated polymers are presented and their efficiency in targeting genes in comparison with that of other available targeted transfection methods is discussed.</p>
</abstract>
</profileDesc>
</hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Hal/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000257 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Hal/Checkpoint/biblio.hfd -nk 000257 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Hal
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Hal:hal-02163748
   |texte=   Glycoconjugates as carriers for specific delivery of therapeutic drugs and genes
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021